Basic profile of Compounds :

• Frontrunners are metabolites of existing non-antibiotic drugs used since the 1960s
• New class of antimicrobial
• Potent against multi-resistant bacteria, vira and fungi
• Synergistic effect in combination with common classic antibiotics
• Reversal of resistance to common antibiotics
• Oral, i.v, i.m, topical administration
• Extensive market potential
• Broad target profile
• Easy and inexpensive to synthesize
• Efficacious in key animal models at doses < NOAEL